{"TopicDetails": {"type": 0, "ccm2Id": 46932868, "cftId": 0, "identifier": "EU4H-2024-PJ-01-3", "title": "Call for proposals to support innovative manufacturing technologies and  processes in the Union for medicines production (HERA) - CP-g-24-12", "publicationDateLong": 1716422400000, "callIdentifier": "EU4H-2024-PJ-01", "callTitle": "HERA Action Grants -  first wave", "callccm2Id": 46932879, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 44176631, "abbreviation": "Improving", "description": "Improving the availability, accessibility and affordability of medicinal products and medical devices, and crisis-relevant products in the Union"}], "topicMGAs": [], "tags": ["STEP-Biotech"], "sme": false, "actions": [{"status": {"id": 31094502, "abbreviation": "Open", "description": "Open"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "23 May 2024", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["05 September 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3541705": [{"action": "EU4H-2024-PJ-01-3 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 17000000}, "budgetTopicActionMap": {}}], "3541707": [{"action": "EU4H-2024-PJ-01-1 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 102000000}, "budgetTopicActionMap": {}}], "3541709": [{"action": "EU4H-2024-PJ-01-2 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 20000000}, "budgetTopicActionMap": {}}], "3541711": [{"action": "EU4H-2024-PJ-01-4 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 10000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p>This action aims at supporting improved manufacturing technologies and processes that allow for a more effective, less expensive, easier to scale up, more sustainable and cleaner production of medicines in the Union. Innovations developed under this action should be designed to enable rapid scale-up of Union pharmaceutical production in the context of a health emergency or to prevent critical shortages of critical medicines. This action supports the Union\u2019s pharmaceutical industry to be better able to respond to public health needs in the context of health emergencies and critical medicines shortages.</p><p>It does so by enabling the development of tools that contribute to the improvement and optimisation of manufacturing of medicines, with the objective of reducing production costs (e.g., related to labour and energy consumption), and facilitating compliance with the Union\u2019s environmental occupational and social requirements, as well as the Union\u2019s current and future needs to scale-up pharmaceutical production. This action supports the policy priority to enhance crisis preparedness and response for future health emergencies in relation to medical countermeasures with an all-threats approach, as well as preventing critical shortages of critical medicines, especially those in a situation of technological vulnerability with regards to the EU market. It implements the EU4Health Programme\u2019s general objective of improving the availability, accessibility and affordability of crisis-relevant products (Article 3, point (c) of Regulation (EU) 2021/522) through the specific objectives defined in Article 4, points (b) and (c), of Regulation (EU) 2021/522.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>This action covers activities aimed at developing support for or innovations targeting the manufacturing of APIs, their intermediates and/or excipients, namely by developing:</p><p>a) novel manufacturing processes and technologies, e.g., additive manufacturing, continuous manufacturing and flow chemistry, and biomanufacturing technologies; combined or not with activities covering:</p><p>b) novel industrial manufacturing and facility designs, e.g., modular manufacturing, smart manufacturing execution systems, including automation and robotics, advanced analytics, and smart sensors, among other.</p><p>Overall, the action should contribute to increasingly sophisticated enhancements to chemical and/or biological processes or decreasing the production of polluting agents. This action is limited to manufacturing technologies and processes and does not cover innovation exclusively targeting the field of quality control.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>This action is expected to result in:</p><p>a) more agile, simplified scale-up, sustainable and resilient manufacturing of APIs, their intermediates, finished products and/or excipients, allowing for better capacity to respond to demand surges and prevent critical shortages of critical medicines.</p><p>b) improved competitiveness of the Union\u2019s manufacturing industry, improved Union\u2019s strategic autonomy and more resilient Union\u2019s industry in the field of medical countermeasures/medicines.</p>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the call document</span>&nbsp;</p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the call document</span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the call document</span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the call document</span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the call document</span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the call document and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the call document</span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the call document</span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2024/call-fiche_eu4h-2024-pj-01_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">Standard application form ([ToA])</a>&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/detailed-budget-table_eu4h_en.xlsx\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">Detailed budget table ([ToA])</a></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">EU4Health Programme General MGA v1.1</a></span></p>\r\n<p style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span class=\"MsoHyperlink\" style=\"box-sizing: inherit;\"><span style=\"box-sizing: inherit;\"><a href=\"https://health.ec.europa.eu/publications/2024-eu4health-work-programme_en\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">EU4Health Work Programme 2024</a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU4Health&nbsp;</span></a><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">Regulation 2021/522</a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><br style=\"box-sizing: inherit;\" />\r\n</span><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU Financial Regulation 2018/1046</span></a></p>\n", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><font face=\"Arial, sans-serif\">HaDEA-HP-CALLS@ec.europa.eu</font></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "EU4H-2024-PJ-01", "status": "Open", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "EU4H-PJG", "criterionDescription": "EU4H Project Grants", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/36919?topic=EU4H-2024-PJ-01-3", "startDate": "May 23, 2024 12:00:00 AM", "endDate": "Sep 5, 2024 5:00:00 PM", "mgaDescription": "EU4H Action Grant Budget-Based", "mgaCode": "EU4H-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "May 23, 2024 12:00:01 AM", "lastChangeDate": "May 23, 2024 12:00:01 AM", "content": "The submission session is now available for: EU4H-2024-PJ-01-1(EU4H-PJG), EU4H-2024-PJ-01-3(EU4H-PJG), EU4H-2024-PJ-01-4(EU4H-PJG), EU4H-2024-PJ-01-2(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": true, "allClosedTopics": false}}}